Treatment of neuroblastoma with 131 I‐metaiodobenzylguanidine: The experience of an Italian study group
Eight patients affected by neuroblastoma were treated with 18 courses of 131 I‐meta‐iodobenzylguanidine (MIBG). They all had been judged as “nonresponders” to conventional treatments. Six had stage IV disease: of these, five, with massive marrow involvement, had poor results, mainly because of marro...
Gespeichert in:
Veröffentlicht in: | Medical and pediatric oncology 1987-01, Vol.15 (4), p.203-204 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!